Skip to main content
星昊医药 logo

星昊医药 — Investor Relations & Filings

Ticker · 920017 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2025-05-29 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920017

About 星昊医药

https://www.sunho.com.cn/

Beijing Sunho Pharmaceutical Co., Ltd. is a technology-driven enterprise specializing in the research, development, manufacturing, and commercialization of advanced pharmaceutical preparations. The company focuses on high-barrier drug delivery systems, including sustained-release, controlled-release, and complex injection technologies. Its core business encompasses the production of a diverse portfolio of chemical drugs and biological products, alongside comprehensive Contract Development and Manufacturing Organization (CDMO) services. Sunho Pharmaceutical operates modern, GMP-compliant production facilities designed to support the entire lifecycle of drug development, from pilot-scale testing to large-scale commercial manufacturing. By leveraging its proprietary formulation platforms, the company provides integrated solutions for complex dosage forms, catering to both domestic and international pharmaceutical markets.

Recent filings

Filing Released Lang Actions
关于选举公司第七届董事会专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of members to the company's seventh board of directors' specialized committees. It details the election process, committee members, and confirms compliance with relevant laws and company governance rules. There is no financial data, audit information, or report content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-05-29 Chinese
第七届监事会第二十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 24th meeting of the 7th Supervisory Board of Beijing Xinghao Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda, and voting results, specifically the election of the Supervisory Board Chairman. There is no financial data, no mention of annual or interim reports, no audit information, and no regulatory filings or certifications. The content focuses on board-level management changes within the supervisory board, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a meeting resolution announcement. Therefore, the classification is MANG with high confidence.
2025-05-29 Chinese
第七届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the first meeting of the seventh board of directors of Beijing Xinghao Pharmaceutical Co., Ltd. It details the election and appointment of the chairman, general manager, deputy general managers, board secretary, financial officer, and members of various board committees. The document includes voting results and confirms compliance with relevant laws and company bylaws. It does not contain financial statements or detailed financial performance data. The content is focused on board and senior management appointments and changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a direct announcement of board decisions, not a report publication announcement or regulatory filing.
2025-05-29 Chinese
2024年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the "2024 Annual Shareholders Meeting Resolution Announcement" for Beijing Xinghao Pharmaceutical Co., Ltd. It details the convening and attendance of the 2024 Annual General Meeting (AGM), including voting results on various proposals such as the 2024 board work report, financial reports, budget, remuneration plans, and election of directors. The document includes detailed voting outcomes and legal opinions confirming the validity of the meeting and resolutions. The content is focused on the official announcement of the AGM resolutions and voting results rather than the full AGM materials or presentations. The document length is about 6,481 characters, which is consistent with an announcement rather than a full report or presentation. Therefore, this document fits best under the category of "Declaration of Voting Results & Voting Rights Announcements (DVA)" as it officially announces the voting results from the AGM.
2025-05-29 Chinese
董事长、高级管理人员换届公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and appointment of the company's chairman and senior management personnel, including their terms, qualifications, and compliance with relevant laws and company regulations. It includes detailed information about the new appointments and their backgrounds. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 2881 characters, which is consistent with an announcement rather than a full report.
2025-05-29 Chinese
章程
Governance Information Classification · 95% confidence The document is a detailed company charter (章程) for Beijing Xinghao Pharmaceutical Co., Ltd., including comprehensive provisions on company organization, shareholder rights, share issuance, share transfer, shareholder meetings, and governance. It references Chinese company law, securities law, and stock exchange listing rules. The content is legal and governance-related, focusing on internal company rules and shareholder meeting procedures rather than financial results or announcements. It is not an announcement, transcript, or report of financial performance but a governance document outlining the company's articles of association. Therefore, the document fits the category of Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2025-05-29 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.